Van Leeuwen & Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Van Leeuwen & Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$6.7M	Sell
2023 Q4	$6.65M	Sell
2023 Q3	$5.69M	Buy
2023 Q2	$3.44M	Buy
2023 Q1	$3.05M	Buy
2022 Q4	$938K	Buy
2020 Q3	–	Sell
2020 Q2	$2.24M	Buy